View Older Stories View More Recent Stories

Jul 25, 2016 02:40PM Trading Radar for 7/26: Apple (AAPL), McDonald's (MCD), 3M (MMM), Caterpillar (CAT), Verizon (VZ), [Conference Call] Under Armour (UA) Report
Jul 19, 2016 08:01AM Eli Lilly & Co. (LLY) Announces FDA Approval of Expanded Synjardy Indication
Jul 19, 2016 08:00AM U.S. FDA expands indication for type 2 diabetes treatment Synjardy® (empagliflozin/metformin hydrochloride) to include treatment-naïve adults
Jul 12, 2016 11:00AM 2016 INVESTIndiana Equity Conference Announces Corporate Presentation Lineup
Jul 6, 2016 06:45AM Lilly Diabetes Welcomes Acclaimed Singer/Songwriter Crystal Bowersox as Newest Spokesperson
Jun 28, 2016 06:22PM FDA Advisory Committee recommends approval of Jardiance® (empagliflozin) for cardiovascular indication in 12-11 vote
Jun 23, 2016 10:00AM Diabetes Scholars Foundation Announces 2016 Scholarship Recipients
Jun 14, 2016 11:01AM Lilly (LLY), Boehringer Ingelheim Announce Publication of Clinically Important Jardiance Data in Reducing Kidney Disease in T2D
Jun 14, 2016 11:00AM Jardiance® (empagliflozin) significantly reduced the risk of progressive kidney disease in adults with type 2 diabetes with established cardiovascular disease
Jun 13, 2016 06:23AM Eli Lilly & Co. (LLY) Announces Significant Data from Trulicity Combo Phase 3 in T2D Glycemic Control
Jun 12, 2016 03:15PM New Data Show Lilly's Once-Weekly Trulicity® (dulaglutide) in Combination with Insulin Glargine Improves Glycemic Control in People with Type 2 Diabetes
Jun 12, 2016 01:00PM New Jardiance® (empagliflozin) data show that reduced risk for cardiovascular (CV) death was consistent across age groups in adults with type 2 diabetes
Jun 11, 2016 11:00AM New Study Findings Underscore Importance of Physician/Patient Communication on Insulin Adherence and Outcomes
Jun 11, 2016 11:00AM New study results show Tradjenta® (linagliptin) reduces blood sugar in adults with type 2 diabetes at risk for kidney impairment
Jun 9, 2016 06:48AM Eli Lilly & Co. (LLY), Incyte (INCY) Report Baricitinib Superiority to Placebo in Inhibiting RA-Related Joint Damage
Jun 9, 2016 06:47AM Eli Lilly & Co. (LLY), Incyte (INCY) Announce Significant Data from Two Baricitinib Phase 3s in RA
Jun 9, 2016 06:45AM Patient-reported outcomes across phase 3 studies of baricitinib demonstrate statistically significant improvements in physical function and quality of life symptoms in patients with rheumatoid arthrit
Jun 9, 2016 06:45AM Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs
May 31, 2016 10:19AM Boehringer Ingelheim and Lilly's (LLY) Jentadueto XR Approved by U.S. FDA
May 31, 2016 10:01AM U.S. FDA Approves Once-daily Jentadueto® XR (linagliptin and metformin hydrochloride extended-release) Tablets for Adults with Type 2 Diabetes
May 2, 2016 12:00PM Largest Independent U.S. Psoriasis Registry to Track Safety of New Biologic Treatment
Apr 25, 2016 03:29PM Trading Radar for 4/26: Apple (AAPL), Chipotle (CMG), Twitter (TWTR), 3M ((MMM), Procter & Gamble (PG), Freeport-McMoRan (FCX) Report
Apr 19, 2016 05:00AM Jardiance® (empagliflozin) to be studied for the treatment of people with chronic heart failure
Apr 6, 2016 07:31AM Incyte (INCY) Acquires Jakafi Commercialization, Development Rights from Lilly (LLY)
Apr 6, 2016 07:30AM Incyte Acquires Rights from Lilly to Develop and Commercialize Ruxolitinib (Jakafi®) for the Treatment of Patients with Graft-Versus-Host Disease (GVHD)
Feb 11, 2016 11:00AM Lilly Diabetes Helps Inspiring Students with Type 1 Diabetes Attend College Through Scholarship Donation
Feb 3, 2016 12:30PM American Diabetes Association® Survey Shows Summer Camp Can Positively Impact Children's Disease Management Skills, Confidence and Stress
Jan 25, 2016 08:33AM FDA Accepts Eli Lilly & Co. (LLY) sNDA for Jardiance Cardiovascular Outcomes Data
Jan 25, 2016 08:30AM U.S. FDA Accepts Filing of Cardiovascular Outcomes Data for Jardiance® (empagliflozin)
Jan 5, 2016 05:33PM Market Wrap: U.S. Auto Sales Have Banner Year; Twitter Said Mulling Key Character-Limit Initiative
Dec 16, 2015 07:18PM FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment
Dec 10, 2015 06:31AM Eli Lilly & Co. (LLY), Merck (MRK) Enter Collaboration for Abemaciclib Phase 1
Dec 10, 2015 06:30AM Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA® Combination Trial
Nov 19, 2015 06:30AM Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial
Nov 9, 2015 10:45AM New Jardiance® (empagliflozin) data show improved CV outcomes regardless of heart failure status at baseline
Nov 6, 2015 08:00AM EMPA-REG OUTCOME®: Top-line renal data to be presented during American Society of Nephrology (ASN) Kidney Week 2015
Nov 3, 2015 09:22AM Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Announce Winners of the My Diabetes Pit Crew Sweepstakes
Oct 16, 2015 03:58PM Top 10 News for 10/9 - 10/16: Dell's Big Buy; Wal-mart's Dire Outlook; Twitter's Busy Week; Square's Imminent IPO
Oct 14, 2015 08:30AM New Type 2 Diabetes Treatment Synjardy® (empagliflozin/metformin hydrochloride) Tablets Now Available in U.S. Pharmacies
Oct 12, 2015 09:31AM Pre-Open Stock Movers 10/12: (ESPR) (OREX) (EMC) Higher; (MHR) (SIEN) (LLY) Lower (more...)
Sep 17, 2015 11:46AM Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial
Aug 27, 2015 10:30AM U.S. FDA approves Synjardy® (empagliflozin/metformin hydrochloride) tablets for adults with type 2 diabetes
Aug 20, 2015 07:30AM Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events
Aug 18, 2015 10:00AM Lilly's Humalog® 200 units/mL KwikPen® Now Available in U.S. Pharmacies
Jul 23, 2015 12:04PM Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Want You to Think About Your Diabetes Pit Crew
Jul 14, 2015 03:00PM Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes
Jun 25, 2015 09:00AM Diabetes Scholars Foundation Announces 2015 Scholarship Recipients
Jun 8, 2015 01:30PM Olympian Kris Freeman and NASCAR Driver Ryan Reed to Share Their Courageous Stories with Children Who Have Type 1 Diabetes
May 27, 2015 08:30AM U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen®
May 27, 2015 07:30AM Boehringer Ingelheim and Lilly Diabetes Alliance to Present Data from 35 Studies at the American Diabetes Association's 75th Scientific Sessions®
View More Recent Stories View Older Stories